Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

447

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Relapsing-remitting Multiple Sclerosis
Interventions
DRUG

Fingolimod

Trial Locations (61)

10437

Novartis Investigative Site, Berlin

10713

Novartis Investigative Site, Berlin

12165

Novartis Investigative Site, Berlin

13347

Novartis Investigative Site, Berlin

16761

Novartis Investigative Site, Hennigsdorf

20249

Novartis Investigative Site, Hamburg

21682

Novartis Investigative Site, Stade

22083

Novartis Investigative Site, Hamburg

24105

Novartis Investigative Site, Kiel

24161

Novartis Investigative Site, Altenholz-Stift

28755

Novartis Investigative Site, Bremen

29223

Novartis Investigative Site, Celle

33611

Novartis Investigative Site, Bielefeld

36043

Novartis Investigative Site, Fulda

37073

Novartis Investigative Site, Göttingen

38300

Novartis Investigative Site, Wolfenbüttel

40225

Novartis Investigative Site, Düsseldorf

41239

Novartis Investigative Site, Mönchengladbach

41515

Novartis Investigative Site, Grevenbroich

44135

Novartis Investigative Site, Dortmund

44787

Novartis Investigative Site, Bochum

44789

Novartis Investigative Site, Bochum

44791

Novartis Investigative Site, Bochum

47800

Novartis Investigative Site, Krefeld

49076

Novartis Investigative Site, Osnabrück

51375

Novartis Investigative Site, Leverkusen

Novartis Investigative Site, Leverkusen

53844

Novartis Investigative Site, Troisdorf

56288

Novartis Investigative Site, Kastellaun

56626

Novartis Investigative Site, Andernach

57076

Novartis Investigative Site, Siegen

60313

Novartis Investigative Site, Frankfurt

63739

Novartis Investigative Site, Aschaffenburg

63755

Novartis Investigative Site, Alzenau in Unterfranken

64711

Novartis Investigative Site, Erbach im Odenwald

66663

Novartis Investigative Site, Merzig

70178

Novartis Investigative Site, Stuttgart

71032

Novartis Investigative Site, Böblingen

72076

Novartis Investigative Site, Tübingen

73430

Novartis Investigative Site, Aalen

73760

Novartis Investigative Site, Ostfildern

76889

Novartis Investigative Site, Klingenmünster

78224

Novartis Investigative Site, Singen

81829

Novartis Investigative Site, München

82008

Novartis Investigative Site, Unterhaching

82335

Novartis Investigative Site, Berg

86633

Novartis Investigative Site, Neuburg am Inn

88477

Novartis Investigative Site, Schwendi

89073

Novartis Investigative Site, Ulm

91054

Novartis Investigative Site, Erlangen

93053

Novartis Investigative Site, Regensburg

93138

Novartis Investigative Site, Lappersdorf

93326

Novartis Investigative Site, Abensberg

96052

Novartis Investigative Site, Bamberg

97980

Novartis Investigative Site, Bad Mergentheim

04299

Novartis Investigative Site, Leipzig

01307

Novartis Investigative Site, Dresden

07740

Novartis Investigative Site, Jena

04157

Novartis Investigative Site, Leipzig

07646

Novartis Investigative Site, Stadtroda

04779

Novartis Investigative Site, Wermsdorf

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY